These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 2144465)
21. Transient myeloproliferative disorder in neonates with and without Down syndrome: a tale of 2 syndromes. Apollonsky N; Shende A; Ouansafi I; Brody J; Atlas M; Aygun B J Pediatr Hematol Oncol; 2008 Nov; 30(11):860-4. PubMed ID: 18989165 [TBL] [Abstract][Full Text] [Related]
22. [Congenital leukaemia and transient myeloproliferative disorder: diagnostic difficulties--case reports]. Jackowska T; Steczowicz M; Pawelec K; Pacholska J Med Wieku Rozwoj; 2006; 10(3 Pt 1):595-601. PubMed ID: 17317890 [TBL] [Abstract][Full Text] [Related]
23. Transient myeloproliferative disorder. In a neonate with Down syndrome. Immunophenotypic studies. Cook JA; Raney B; Innes DJ; Normansell D Clin Pediatr (Phila); 1989 Mar; 28(3):132-5. PubMed ID: 2522030 [TBL] [Abstract][Full Text] [Related]
24. Transient myeloproliferative disease of the newborn: case report with placental, cytogenetic, and flow cytometric findings. de Tar MW; Dittman W; Gilbert J Hum Pathol; 2000 Mar; 31(3):396-8. PubMed ID: 10746686 [TBL] [Abstract][Full Text] [Related]
25. Test and teach. Number Seventy. Diagnosis: Transient myeloproliferative disorder in a child with Down's syndrome. Wright SJ; Kerwick AM; Rodwell RL; Taylor KM Pathology; 1993 Apr; 25(2):133, 207-8. PubMed ID: 8367191 [No Abstract] [Full Text] [Related]
26. Transient myeloproliferative disorder progression and acquired chromosomal abnormalities in children with Down syndrome. Picos Cárdenas VJ; Meza Espinoza JP; Garibaldi Covarrubias RF; Barajas Torres RL; González García JR Pediatr Blood Cancer; 2012 Nov; 59(5):962-3. PubMed ID: 22811256 [No Abstract] [Full Text] [Related]
27. Transient myeloproliferative disorder causing a vesiculopustular eruption in a phenotypically normal neonate. Solky BA; Yang FC; Xu X; Levins P Pediatr Dermatol; 2004; 21(5):551-4. PubMed ID: 15461760 [TBL] [Abstract][Full Text] [Related]
28. Blast cell deficiency of CD11a as a marker of acute megakaryoblastic leukemia and transient myeloproliferative disease in children with and without Down syndrome. Boztug H; Schumich A; Pötschger U; Mühlegger N; Kolenova A; Reinhardt K; Dworzak M Cytometry B Clin Cytom; 2013; 84(6):370-8. PubMed ID: 23450818 [TBL] [Abstract][Full Text] [Related]
29. Mutation of the AML1/RUNX1 gene in a transient myeloproliferative disorder patient with Down syndrome. Taketani T; Taki T; Takita J; Ono R; Horikoshi Y; Kaneko Y; Sako M; Hanada R; Hongo T; Hayashi Y Leukemia; 2002 Sep; 16(9):1866-7. PubMed ID: 12200707 [No Abstract] [Full Text] [Related]
30. Vesiculopustular eruption in a neonate with trisomy 21 syndrome as a clue of transient myeloproliferative disorders. Piersigilli F; Diociaiuti A; Boldrini R; Auriti C; Curci M; El Hachem M; Seganti G Cutis; 2010 Jun; 85(6):286-8. PubMed ID: 20666188 [TBL] [Abstract][Full Text] [Related]
31. [GATA1 analysis in myeloproliferative disorders associated to trisomy 21]. Fuster Soler JL; Norton A; Galera Miñarro A; Bermúdez Cortés M; Llinares Riestra ME; Ortuño Giner F An Pediatr (Barc); 2011 Jan; 74(1):31-7. PubMed ID: 20870473 [TBL] [Abstract][Full Text] [Related]
32. Neonatal vesiculopustular eruption of the face: a sign of trisomy 21-associated transient myeloproliferative disorder. Moriuchi R; Shibaki A; Yasukawa K; Onozuka T; Sato T; Kaneda M; Iguchi A; Kobayashi R; Shimizu H Br J Dermatol; 2007 Jun; 156(6):1373-4. PubMed ID: 17459046 [No Abstract] [Full Text] [Related]
33. Development of acute megakaryoblastic leukemia from a minor clone in a Down syndrome patient with clinically overt transient myeloproliferative disorder. Xu G; Kato K; Toki T; Takahashi Y; Terui K; Ito E J Pediatr Hematol Oncol; 2006 Oct; 28(10):696-8. PubMed ID: 17023834 [TBL] [Abstract][Full Text] [Related]
34. A 15q24 microdeletion in transient myeloproliferative disease (TMD) and acute megakaryoblastic leukaemia (AMKL) implicates PML and SUMO3 in the leukaemogenesis of TMD/AMKL. Haemmerling S; Behnisch W; Doerks T; Korbel JO; Bork P; Moog U; Hentze S; Grasshoff U; Bonin M; Rieß O; Janssen JW; Jauch A; Bartram CR; Reinhardt D; Koch KA; Bandapalli OR; Kulozik AE Br J Haematol; 2012 Apr; 157(2):180-7. PubMed ID: 22296450 [TBL] [Abstract][Full Text] [Related]
35. Transient myeloproliferative disorder (transient leukemia) and hematologic manifestations of Down syndrome. Zipursky A; Brown EJ; Christensen H; Doyle J Clin Lab Med; 1999 Mar; 19(1):157-67, vii. PubMed ID: 10403079 [TBL] [Abstract][Full Text] [Related]
36. [GATA1-mutation associated leukemia in children with trisomy 21 mosaic]. Reinhardt D; Reinhardt K; Neuhoff C; Sander A; Klusmann JH; Pekrun A; Sauerbrey A; von Stackelberg A; Rössig C; Creutzig U; Kolenova A Klin Padiatr; 2012 Apr; 224(3):153-5. PubMed ID: 22513796 [TBL] [Abstract][Full Text] [Related]